Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event

The increase of global cases of drug resistant (DR) Mycobacterium tuberculosis (M.tb) is a serious problem for the tuberculosis research community and the goals to END TB by 2030. Due to the need for advancing and screening next generation therapeutics and vaccines, we aimed to design preclinical DR...

Descripción completa

Detalles Bibliográficos
Autores principales: Berube, Bryan J., Larsen, Sasha E., McNeil, Matthew B., Reese, Valerie A., Pecor, Tiffany, Kaur, Suhavi, Parish, Tanya, Baldwin, Susan L., Coler, Rhea N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019580/
https://www.ncbi.nlm.nih.gov/pubmed/36375278
http://dx.doi.org/10.1016/j.tube.2022.102272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019580/
https://www.ncbi.nlm.nih.gov/pubmed/36375278
http://dx.doi.org/10.1016/j.tube.2022.102272

Ejemplares similares